Search Results 181-190 of 16999 for Cannabis

  1. Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

    The concurrent use of all herbal supplements is prohibited during the study (including, but not limited to, cannabis, St. John's wort, kava, ephedra [ma ...

  2. Quetiapine (oral route) - Side effects & dosage - Mayo Clinic

    Cannabis; Carbamazepine; Carbidopa. Show More. Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but ...

  3. Ketamine Infusions in Clinically Depressed ICU Patients

    Patient in withdrawal from substance abuse or who have used hallucinogens (including cannabis) in the last month for any indication, as determined by the ...

  4. A Study to Evaluate Precision Pharmacogenomics in Cancer Patients - Mayo Clinic

    About this study. THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a ...

  5. https://www.mayoclinic.org/chinese_organization_concepts.xml

  6. Intervention: Help a loved one overcome addiction - Mayo Clinic

    An intervention can motivate someone to seek help for alcohol or drug misuse, compulsive eating, or other addictive behaviors. Discover when to hold one and ...

  7. Publications - Aoife M. Egan, M.B., B.Ch., Ph.D. - Mayo Clinic

    The effects of recreational cannabis use on glycemic outcomes and self-management behaviours in people with type 1 and type 2 diabetes: a rapid review. Syst ...

  8. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    Subject has cannabis use either recreational or for medical reasons within 14 days prior to Baseline or any history of clinically significant (per ...

  9. A Study for the Treatment of Primary Obesity - Mayo Clinic

    Patient is currently using marijuana/cannabis for either medicinal or recreational use, or has plans to start using over the next 12 months. Present or ...

  10. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    Subject who has concomitant cannabis use either recreational or for medical reasons within 14 days prior to Baseline or any history of clinically ...